References
Benz C, Schoenberg M, Choti M, Cadman E: Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. J Clin Invest 66:1162–1165, 1980
Ringborg U, Ewert G, Kinnman J, Lundquist P-G, Strander H: Methotrexate and 5-fluorouracil in head and neck cancer. Semin Oncol 10 (Suppl 2):20–22, 1983
Ajani JA, Kanojia MD, Bedikian AY, Korinek JK, Stein SH, Espinoza EG, Bodey GP: Sequential methotrexate and 5-fluorouracil in the primary treatment of metastatic colorectal carcinoma. Am J Clin Oncol 8:69–71, 1985
Tisman G, Wu SJG: Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as a sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon. Cancer Treat Rep 64:829–835, 1980
Krivit W, Bentley HP: Use of 5-fluorouracil in the management of advanced malignancies in childhoos. Am J Dis Child 100:217–227, 1960
Bode U: Methotrexate as relapse therapy for rhabdomyosarcoma. Am J Pediatr Hematol Oncol 8:70–72, 1986
Benz C, Degregorio M, Saks S, Sambol N, Holleran W, Ignoffo R, Lewis B, Cadman E: Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. Cancer Res 45:3354–3358, 1985
Falk LC, Clark DR, Kalman SM, Long TF: Enzymatic assay for methotrexate in serum and cerebrospinal fluid. Clin Chem 22:785–788, 1976
Murphy RF, Balis FM, Poplack DG: The stability of 5-fluorouracil in plasma and whole blood. Clin Chem 33:2299–2300, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balis, F.M., Gillespie, A., Belasco, J. et al. Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs 8, 181–182 (1990). https://doi.org/10.1007/BF00177254
Issue Date:
DOI: https://doi.org/10.1007/BF00177254